These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31859203)

  • 1. Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Clark A
    Vaccine; 2020 Feb; 38(6):1277-1279. PubMed ID: 31859203
    [No Abstract]   [Full Text] [Related]  

  • 2. Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.
    Cohen AL; Aliabadi N; Serhan F; Tate JE; Zuber P; Parashar UD
    Vaccine; 2018 Dec; 36(51):7755-7758. PubMed ID: 30131194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
    Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].
    Sun SL; Gao YQ; Yin J; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):238-42. PubMed ID: 26917523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
    PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.
    Kang HY; Kim KH; Kim JH; Kim HM; Kim J; Kim MS; El Khoury AC; Kim DS
    Asia Pac J Public Health; 2013 Mar; 25(2):145-58. PubMed ID: 22234827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
    Sarker AR; Sultana M; Mahumud RA; Van Der Meer R; Morton A
    Hum Vaccin Immunother; 2018 Jan; 14(1):189-198. PubMed ID: 29099653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.
    Lorgelly PK; Joshi D; Iturriza Gómara M; Gray J; Mugford M
    Epidemiol Infect; 2008 Jan; 136(1):44-55. PubMed ID: 17335631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
    Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
    Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece.
    Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A
    Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.
    Suwantika AA; Tu HA; Postma MJ
    Vaccine; 2013 Jul; 31(32):3300-7. PubMed ID: 23707163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
    Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study.
    Debellut F; Clark A; Pecenka C; Tate J; Baral R; Sanderson C; Parashar U; Kallen L; Atherly D
    Lancet Glob Health; 2019 Dec; 7(12):e1664-e1674. PubMed ID: 31708147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic assessment of rotavirus vaccination in Saudi Arabia.
    Al-Aidaroos AYA; Standaert B; Meszaros K; Shibl AM
    J Infect Public Health; 2017; 10(5):564-571. PubMed ID: 28214189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.